Live feed
Filing
SC 13D
SC 13D0001387131-20-008761·Session R.A. II
Schedule 13D ownership disclosure
Taysha Gene Therapies Inc
Security class unavailable · CUSIP: 877619106
Event date: 2020-09-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,430,582
- Percent of class
- 25.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-20-008761
- Form type
- SC 13D
- Filer
- Session R.A. II
- CIK
- CIK 1701846
- Filed
- Oct 05, 2020
- Reporting period
- Sep 23, 2020
- Description
- Schedule 13D beneficial ownership